ABSTRACT
I begin here by considering some biopolitical processes within molecular animal breeding that may be seen as especially bound up in hopes for new ways of capitalizing on animal bodies. e expected protability of the molecular turn, I argue, revolves around two interrelated methods of capitalization: rst, research on a nexus of speed, accuracy and eciency, and, second, research on the possibility of hybridity. Here I also consider some of the general literature on genomics and ideas of ‘biocapital’,1 before then going on to situate capitalization within the broader discourse of the knowledge economy. I also consider some of the ways in which genomics is already being made protable, as well as the relevant emergent relationships between science and the animal breeding corporate sphere.
